Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TAFAMIDIS vs TAFASITAMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TAFAMIDIS vs TAFASITAMAB: Safety Overview

Metric TAFAMIDIS TAFASITAMAB
Total FAERS Reports 9,202 1,392
Deaths Reported 3,343 475
Death Rate 36.3% 34.1%
Hospitalizations 2,284 433
Average Patient Age 80.7 yrs 70.0 yrs
% Female Patients 20.7% 50.1%
FDA Approval Date May 3, 2019 N/A
Manufacturer Pfizer Laboratories Div Pfizer Inc Incyte Corporation
Route N/A INTRAVENOUS
Marketing Status Prescription N/A